News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
868,848 Results
Type
Article (87849)
Company Profile (775)
Press Release (780207)
Multimedia
Podcasts (204)
Webinars (30)
Section
Business (233134)
Career Advice (4148)
Deals (39889)
Drug Delivery (148)
Drug Development (91386)
Employer Resources (205)
FDA (18383)
Job Trends (17431)
News (397662)
Policy (39889)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3016)
Academic (1)
Accelerated approval (36)
Adcomms (33)
Allergies (148)
Alliances (56953)
ALS (183)
Alzheimer's disease (1809)
Antibody-drug conjugate (ADC) (361)
Approvals (18590)
Artificial intelligence (609)
Autoimmune disease (180)
Automation (43)
Bankruptcy (404)
Best Places to Work (12622)
BIOSECURE Act (23)
Biosimilars (211)
Biotechnology (476)
Bladder cancer (164)
Brain cancer (64)
Breast cancer (676)
Cancer (5133)
Cardiovascular disease (428)
Career advice (3572)
Career pathing (42)
CAR-T (316)
CDC (38)
Celiac Disease (1)
Cell therapy (856)
Cervical cancer (37)
Clinical research (77146)
Collaboration (1890)
Company closure (4)
Compensation (1163)
Complete response letters (76)
COVID-19 (2978)
CRISPR (106)
C-suite (907)
Cystic fibrosis (155)
Data (6453)
Decentralized trials (2)
Denatured (75)
Depression (152)
Diabetes (492)
Diagnostics (7202)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (291)
Drug pricing (195)
Drug shortages (30)
Duchenne muscular dystrophy (254)
Earnings (99787)
Editorial (64)
Employer branding (25)
Employer resources (174)
Events (134990)
Executive appointments (1011)
FDA (21575)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1565)
Gene editing (224)
Generative AI (58)
Gene therapy (700)
GLP-1 (1099)
Government (5370)
Grass and pollen (5)
Guidances (356)
Healthcare (20905)
HIV (59)
Huntington's disease (52)
IgA nephropathy (87)
Immunology and inflammation (296)
Immuno-oncology (72)
Indications (122)
Infectious disease (3253)
Inflammatory bowel disease (214)
Inflation Reduction Act (15)
Influenza (120)
Intellectual property (256)
Interviews (817)
IPO (17906)
IRA (49)
Job creations (5201)
Job search strategy (2867)
JPM (70)
Kidney cancer (18)
Labor market (97)
Layoffs (648)
Leadership (40)
Legal (10129)
Liver cancer (98)
Longevity (17)
Lung cancer (702)
Lymphoma (387)
Machine learning (45)
Management (66)
Manufacturing (848)
MASH (177)
Medical device (14976)
Medtech (15033)
Mergers & acquisitions (22976)
Metabolic disorders (1352)
mRNA (198)
Multiple sclerosis (174)
NASH (23)
Neurodegenerative disease (370)
Neuropsychiatric disorders (101)
Neuroscience (3166)
Neurotech (1)
NextGen: Class of 2026 (7703)
Non-profit (5108)
Now hiring (68)
Obesity (655)
Opinion (339)
Ovarian cancer (166)
Pain (214)
Pancreatic cancer (241)
Parkinson's disease (307)
Partnered (37)
Patents (510)
Patient recruitment (528)
Peanut (63)
People (66906)
Pharmaceutical (135)
Pharmacy benefit managers (28)
Phase 1 (23864)
Phase 2 (33509)
Phase 3 (25205)
Pipeline (5631)
Policy (313)
Postmarket research (3552)
Preclinical (10708)
Press Release (72)
Prostate cancer (264)
Psychedelics (59)
Radiopharmaceuticals (312)
Rare diseases (964)
Real estate (7440)
Recruiting (81)
Regulatory (29106)
Reports (66)
Research institute (2727)
Resumes & cover letters (652)
Rett syndrome (28)
RNA editing (21)
RSV (76)
Schizophrenia (162)
Series A (271)
Series B (202)
Service/supplier (26)
Sickle cell disease (106)
Special edition (28)
Spinal muscular atrophy (177)
Sponsored (49)
Startups (4336)
State (2)
Stomach cancer (20)
Supply chain (102)
Tariffs (82)
The Weekly (127)
Vaccines (1090)
Venture capital (100)
Weight loss (436)
Women's health (97)
Worklife (22)
Date
Today (259)
Last 7 days (809)
Last 30 days (2723)
Last 365 days (30764)
2026 (4551)
2025 (30961)
2024 (37018)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1287)
Alabama (94)
Alaska (7)
Arizona (325)
Arkansas (14)
Asia (51606)
Australia (9070)
California (11590)
Canada (3178)
China (1200)
Colorado (454)
Connecticut (474)
Delaware (351)
Europe (118458)
Florida (1669)
Georgia (366)
Hawaii (4)
Idaho (66)
Illinois (911)
India (74)
Indiana (526)
Iowa (24)
Japan (455)
Kansas (135)
Kentucky (43)
Louisiana (24)
Maine (63)
Maryland (1424)
Massachusetts (8636)
Michigan (333)
Minnesota (658)
Mississippi (6)
Missouri (128)
Montana (35)
Nebraska (29)
Nevada (123)
New Hampshire (85)
New Jersey (3073)
New Mexico (32)
New York (3000)
North Carolina (1622)
North Dakota (10)
Northern California (5630)
Ohio (352)
Oklahoma (22)
Oregon (53)
Pennsylvania (2306)
Puerto Rico (24)
Rhode Island (50)
South America (1665)
South Carolina (66)
South Dakota (1)
Southern California (4473)
Tennessee (133)
Texas (1790)
United States (41334)
Utah (298)
Vermont (1)
Virginia (267)
Washington D.C. (81)
Washington State (977)
West Virginia (3)
Wisconsin (135)
Wyoming (1)
868,848 Results for "bio thera solutions ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
February 13, 2026
·
7 min read
Press Releases
Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion
December 12, 2025
·
7 min read
Press Releases
The European Commission (EC) Approves Bio-Thera Solutions’ BAT2206 (USYMRO®, ustekinumab), a biosimilar referencing Stelara®
August 27, 2025
·
5 min read
Press Releases
Bio-Thera Solutions Announces Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in Canada
October 10, 2025
·
6 min read
Press Releases
Bio-Thera and STADA Extend Biosimilars Alliance to Tocilizumab
August 24, 2025
·
6 min read
Press Releases
Bio-Thera Solutions Receives Positive CHMP Opinion for USYMRO®(ustekinumab), a Biosimilar Referencing Stelara®
June 20, 2025
·
5 min read
Press Releases
Bio-Thera Solutions Announces FDA Accepts Biologics License Application for BAT2506, a Proposed Biosimilar to Simponi®
July 17, 2025
·
7 min read
Press Releases
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
January 29, 2026
·
6 min read
Press Releases
Bio-Thera Solutions and SteinCares Expand Partnership to Commercialize Biosimilars for Treatment of Inflammatory Diseases Across Latin America
June 25, 2025
·
5 min read
Business
Bio-Thera Solutions Partners with SteinCares to Market Two Biosimilars in LATAM
Bio-Thera Solutions announced today a new licensing agreement for two biosimilars under which SteinCares will have exclusive rights to distribute and market Bio-Thera’s pharmaceuticals in Brazil and the rest of the region.
March 18, 2024
·
5 min read
1 of 86,885
Next
